EBV infection of human B lymphocytes leads to down-regulation of Bim expression: relationship to resistance to apoptosis

J Immunol. 2005 Sep 1;175(5):2968-73. doi: 10.4049/jimmunol.175.5.2968.

Abstract

EBV infects a large proportion of the human population worldwide and is one of the major viruses with human B lymphocyte tropism. It can immortalize human B lymphocytes and controls their resistance to apoptosis. EBV infection is associated with several lymphomas, including Burkitt's lymphoma. In this report we show that EBV infection leads to the post-transcriptional down-regulation of expression of the proapoptotic protein Bim. This process involves the phosphorylation of BimEL by the constitutive EBV-activated kinase ERK1/2, followed by its degradation through the proteasome pathway. We also show that ectopic expression of BimEL in EBV-positive Burkitt's lymphoma cells can enhance the sensitivity of these cells to serum deprivation-dependent apoptosis. Thus, EBV-mediated resistance to growth factor deprivation in human B lymphocytes is dependent on BimEL expression. Our data suggest that this regulatory pathway is an important contributor to the oncogenic potential of EBV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics*
  • Apoptosis Regulatory Proteins
  • Apoptosis*
  • B-Lymphocytes / pathology
  • B-Lymphocytes / virology*
  • Bcl-2-Like Protein 11
  • Down-Regulation
  • Extracellular Signal-Regulated MAP Kinases / physiology
  • Gene Expression Regulation*
  • Herpesvirus 4, Human / pathogenicity*
  • Humans
  • Membrane Proteins
  • Proto-Oncogene Proteins

Substances

  • Adaptor Proteins, Signal Transducing
  • Apoptosis Regulatory Proteins
  • BCL2L11 protein, human
  • Bcl-2-Like Protein 11
  • Membrane Proteins
  • Proto-Oncogene Proteins
  • Extracellular Signal-Regulated MAP Kinases